x

Posted 14 July, 2021

BIOLIFE SOLUTIONS INC appointed new CEO

CEO Change detected for ticker Nasdaq:BLFS in a 8-K filed on 14 July, 2021.


  On July 13, 2021, to fill the vacancies caused by Mr. Cohen's resignation, the Board of Directors appointed Michael Rice, the Chief Executive Officer and a director of the Company, as Chairman of the Board of Directors, and appointed Amy DuRoss to the Audit Committee, Joseph Schick to the Compensation Committee and Rachel Ellingson to the Nominating and Governance Committee.  

Don't how to trade CEO change? Read Reasons for CEO Turnover and Effect on Stock Performance.
Overview of BIOLIFE SOLUTIONS INC
Health Care/Life Sciences • Medical Equipment/Supplies
BioLife Solutions, Inc. engages in the development, manufacture and marketing of bio preservation tools for cells and tissues. Its product offerings include proprietary hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs, generic blood stem cell freezing and cell thawing media products and custom product formulation and custom packaging services. The company was founded by Boris Rubinsky in 1987 and is headquartered in Bothell, WA.
Market Cap
$822M
View Company Details
BIOLIFE SOLUTIONS INC by TradingView
Relevant filing section
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

On July 12, 2021, Raymond Cohen, the Chairman of the Board of Directors of BioLife Solutions, Inc. (the "Company"), resigned from the Board of Directors and all committees thereto. Mr. Cohen's resignation was not the result of a disagreement with the Company on any matter relating to the Company's operations, policies or practices.

 

On July 13, 2021, to fill the vacancies caused by Mr. Cohen's resignation, the Board of Directors appointed Michael Rice, the Chief Executive Officer and a director of the Company, as Chairman of the Board of Directors, and appointed Amy DuRoss to the Audit Committee, Joseph Schick to the Compensation Committee and Rachel Ellingson to the Nominating and Governance Committee.